Mei-Sze Chua

5PUBLICATIONS
7CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 27, 2026
A Novel Niclosamide Sulfate Prodrug with Enhanced Bioavailability Suppresses Hepatocellular Carcinoma via Inhibition of Multiple Signaling Pathways.

|Mar 19, 2024
Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice.

Yi Liu, David Quintanar Guerrero, David Lechuga-Ballesteros

|Oct 14, 2023
Identification and validation of microtubule depolymerizing agent, CYT997, as a potential drug candidate for hepatocellular carcinoma.

Faiz Ahmad, Li Ma, Wei Wei

|Jan 08, 2020
High Inflammatory Factor Grading Predicts Poor Disease-Free Survival in AJCC Stage I-II Hepatocellular Carcinoma Patients After R0 Resection.

Mao Zhang, Mei-Sze Chua, Jie Hu

|Nov 01, 2019
An Automated, Quantitative, and Multiplexed Assay Suitable for Point-of-Care Hepatitis B Virus Diagnostics.

Adi Wijaya Gani, Wei Wei, Run-Zhang Shi

Pageof 1

Frequent Collaborators

2 joint publications

Yi Liu

1 joint publications

Mao Zhang

1 joint publications

Bing Han

1 joint publications

Mingdian Tan